Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Current Assets (2023 - 2025)

Rallybio's Current Assets history spans 3 years, with the latest figure at $50.3 million for Q2 2025.

  • For Q2 2025, Current Assets fell 45.03% year-over-year to $50.3 million; the TTM value through Jun 2025 reached $50.3 million, down 45.03%, while the annual FY2024 figure was $67.8 million, 40.9% down from the prior year.
  • Current Assets for Q2 2025 was $50.3 million at Rallybio, down from $67.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $161.3 million in Q1 2023 and bottomed at $50.3 million in Q2 2025.
  • The 3-year median for Current Assets is $106.7 million (2023), against an average of $107.9 million.
  • The largest annual shift saw Current Assets tumbled 37.73% in 2024 before it crashed 45.03% in 2025.
  • A 3-year view of Current Assets shows it stood at $114.8 million in 2023, then tumbled by 40.9% to $67.8 million in 2024, then decreased by 25.91% to $50.3 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Current Assets are $50.3 million (Q2 2025), $67.8 million (Q4 2024), and $91.4 million (Q2 2024).